COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer
Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer -
-
-
COMMUNIQUÉ DE PRESSE
Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Prospect Ridge Resources Corp. closes non-brokered flow-through private placement of $450,000 for mineral exploration expenses in British Columbia. Company allocates funds to 2026 drill programs at Excalibur, Castle, and Camelot projects -
-
COMMUNIQUÉ DE PRESSE
aap successfully completes MDR certification: All existing products approved according to MDR – market access in the EU and CE-relevant markets secured in the long term
aap Implantate AG successfully completes MDR certification for all existing products, ensuring market access in EU and CE-relevant markets in the long term. Focus shifts to new product development -
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Covivio - Conditions of availability of the 2025 Universal Registration Document
Covivio announces availability of its 2025 Universal Registration Document in ESEF format, filed with AMF and accessible on its website and AMF's site. Includes financial report, sustainability report, governance report, and auditors' reports
